Effect of domperidone (leisguard®) on antibody titers, inflammatory markers and creatinine in dogs with leishmaniosis and chronic kidney disease

BACKGROUND: Immunotherapeutic drugs, such as domperidone, have been shown to be promising treatments against canine leishmaniosis (CanL), but limited data are available. The aim of this pilot study (therapeutic, prospective and non-controlled) was to evaluate the effect of domperidone on serum antib...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalera, Maria Alfonsa, Gernone, Floriana, Uva, Annamaria, D’Ippolito, Paola, Roura, Xavier, Paltrinieri, Saverio, Zatelli, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504065/
https://www.ncbi.nlm.nih.gov/pubmed/34629081
http://dx.doi.org/10.1186/s13071-021-05030-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504065/
https://www.ncbi.nlm.nih.gov/pubmed/34629081
http://dx.doi.org/10.1186/s13071-021-05030-8

Ejemplares similares